Sedation Management for Pediatric Patients

Medication Options and Dosing

The American Academy of Pediatrics recommends ketamine as the first-line sedative agent for pediatric patients, administered at 1-1.5 mg/kg IV with atropine 0.01 mg/kg 1
Ketamine provides both analgesia and sedation, and maintains airway reflexes and respiratory drive, making it particularly useful for potentially painful procedures 1
For IM administration of ketamine, the dose is 4-5 mg/kg if IV access cannot be established 1
The American Academy of Pediatrics suggests considering adding glycopyrrolate (5 μg/kg) to reduce secretions when using ketamine 1
Midazolam can be used as a second-line option, with an IV dose of 0.05-0.1 mg/kg given over 2-3 minutes (maximum single dose: 5 mg) 2
Pentobarbital is not recommended as a first-line option for pediatric patients ≥12 years old or >50 kg due to decreased efficacy 3

The American Academy of Pediatrics recommends continuous pulse oximetry and cardiac monitoring throughout the procedure 4
Capnography is recommended to detect respiratory depression earlier than pulse oximetry alone 2
Vital sign monitoring should be performed at least every 5 minutes during the procedure 4
Dedicated personnel should be assigned for monitoring, separate from the provider performing the procedure 4

A pre-sedation assessment should include verification of ASA physical status (ideally I or II for procedural sedation) and assessment of the airway for potential difficulties 4
The American Academy of Pediatrics recommends checking for contraindications to the selected sedative 1
Equipment requirements include immediate availability of age and size-appropriate airway equipment, resuscitation medications, supplemental oxygen, and suction devices 4

Ketamine may cause emergence reactions, particularly in older children (>10 years), and consideration should be given to adding midazolam (0.05 mg/kg) to reduce emergence reactions in this age group 1
Ketamine may cause laryngospasm, a rare but serious complication, and monitoring is recommended 1
Midazolam has a shorter recovery time than pentobarbital, but may cause paradoxical agitation in some patients 2
Pentobarbital has a longer recovery time compared to other options (up to 100 minutes) and is less effective in children ≥12 years old or >50 kg 3

The American Academy of Pediatrics recommends ensuring adequate staffing for safe medication administration and physical restraint if needed 4
Consideration should be given to the underlying cause of aggression (pain, fear, psychiatric condition) when selecting a sedation strategy 5
For extremely aggressive patients, a sequential approach may be considered, including verbal de-escalation, IM midazolam or ketamine, and transition to IV medications once initial sedation is achieved 1

Benzodiazepines should not be used alone for painful procedures as they provide no analgesia 5
The maximum recommended doses of any sedative agent should not be exceeded 4
Respiratory depression with midazolam, particularly when combined with opioids, should be monitored 5
Ketamine should be avoided in patients with increased intracranial pressure or psychosis 1